AstraZeneca news from FierceHealthcare
News
AstraZeneca asks judge to nullify $215M drug-price lawsuit
Drugmaker AstraZeneca has asked an Alabama judge to nullify a jury verdict that ordered it to pay the state $215 million in damages in a Medicaid drug-price fraud suit. The state's 2005 suit accused Read more...
FTC: Pharmas cut 14 deals to delay generic sales in '07
Makers of brand-name prescription drugs reached 14 agreements with makers of generic drugs to delay the generic drug makers entry into the market, according to a new report released by the Federal Read more...
Drug companies plan to disclose grant funding
Hoping to stave off outside regulation by Congress, a group of the nation's largest drug and device manufacturers have put forth plans to publicly disclose the grants they make to outside Read more...
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies